Tivic Health Systems, Inc.
TIVC
$3.50
-$0.18-4.89%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -49.58% | -55.32% | -13.04% | -11.17% | -12.50% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -49.58% | -55.32% | -13.04% | -11.17% | -12.50% |
| Cost of Revenue | 19.03% | -52.87% | 10.00% | -36.50% | -3.56% |
| Gross Profit | -4,880.00% | -59.26% | -50.82% | 47.79% | -88.37% |
| SG&A Expenses | -48.60% | -31.22% | -45.63% | -19.95% | 1.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -33.76% | -23.75% | -41.12% | -27.17% | -2.36% |
| Operating Income | 31.24% | 18.69% | 43.25% | 30.01% | 0.53% |
| Income Before Tax | 34.15% | 18.69% | 40.42% | 30.01% | 0.49% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 34.15% | 18.69% | 40.42% | 30.01% | 0.49% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 34.15% | 18.69% | 40.42% | 30.01% | 0.49% |
| EBIT | 31.24% | 18.69% | 43.25% | 30.01% | 0.53% |
| EBITDA | 31.18% | 18.75% | 43.19% | 29.99% | 0.49% |
| EPS Basic | 87.64% | 84.37% | 95.59% | 90.40% | -- |
| Normalized Basic EPS | 87.13% | 84.37% | 95.59% | 90.40% | -- |
| EPS Diluted | 87.64% | 84.37% | 95.59% | 90.40% | -- |
| Normalized Diluted EPS | 87.13% | 84.37% | 95.59% | 90.40% | -- |
| Average Basic Shares Outstanding | 432.41% | 420.29% | 1,248.00% | 631.36% | -- |
| Average Diluted Shares Outstanding | 432.41% | 420.29% | 1,248.00% | 631.36% | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |